Tiny OncoSec Surges on Promising Phase II Melanoma Data Post author:Sam Post published:November 7, 2017 Post category:BioPharma The updated data will be presented at the 2017 Society for Immunotherapy of Cancer Annual Meeting. Source: BioSpace You Might Also Like Vertex Pharmaceuticals Appoints Reshma Kewalramani as New CMO February 25, 2018 Astellas Takes Out Massachusetts' Biotech Mitobridge in $390M Deal November 30, 2017 Genentech Will Pass Out More Cash to Researchers to May 17, 2017